SubHero Banner
Text

Tresiba® (insulin degludec) – First-time authorized brand alternative

September 8, 2022 - Novo Nordisk announced the launch of an authorized brand alternative (ABA) of its Tresiba (insulin degludec) injection.

Download PDF

Text